| __timestamp | Lantheus Holdings, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 8393000000 |
| Thursday, January 1, 2015 | 14358000 | 7690000000 |
| Friday, January 1, 2016 | 12203000 | 7872000000 |
| Sunday, January 1, 2017 | 18125000 | 7657000000 |
| Monday, January 1, 2018 | 17071000 | 8006000000 |
| Tuesday, January 1, 2019 | 20018000 | 8650000000 |
| Wednesday, January 1, 2020 | 32788000 | 9405000000 |
| Friday, January 1, 2021 | 44966000 | 13829000000 |
| Saturday, January 1, 2022 | 311681000 | 11428000000 |
| Sunday, January 1, 2023 | 77707000 | 10679000000 |
| Monday, January 1, 2024 | 10930000000 |
Cracking the code
In the ever-evolving pharmaceutical landscape, research and development (R&D) is the lifeblood of innovation. Over the past decade, Pfizer Inc. and Lantheus Holdings, Inc. have demonstrated contrasting R&D investment strategies. Pfizer, a global pharmaceutical giant, consistently allocated substantial resources, with R&D expenses peaking at approximately $13.8 billion in 2021. This represents a 70% increase from 2014, underscoring Pfizer's commitment to pioneering medical breakthroughs.
Conversely, Lantheus Holdings, Inc., a smaller player, exhibited a more volatile R&D trajectory. Notably, their R&D spending surged by over 500% from 2014 to 2022, reaching a high of $311 million. This dramatic rise highlights Lantheus's strategic pivot towards innovation-driven growth.
These divergent paths reflect broader industry trends, where established firms leverage scale, while emerging companies capitalize on agility to drive innovation.
Research and Development Expenses Breakdown: AbbVie Inc. vs Pfizer Inc.
Research and Development Expenses Breakdown: Pfizer Inc. vs GSK plc
Who Prioritizes Innovation? R&D Spending Compared for Pfizer Inc. and Amicus Therapeutics, Inc.
Research and Development Expenses Breakdown: Pfizer Inc. vs HUTCHMED (China) Limited
Analyzing R&D Budgets: Pfizer Inc. vs BioCryst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: argenx SE vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Lantheus Holdings, Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Lantheus Holdings, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and ADMA Biologics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Soleno Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Mesoblast Limited
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs BioCryst Pharmaceuticals, Inc.